Canadian Hemophilia Society -

Title

COVID-19 updates
CHS/SCH | 14/10/2020
Access the most updated information regarding COVID-19 and inherited bleeding disorders: www.hemophilia.ca/covid-19

WFH Advisory: availability of desmopressin
CHS/SCH | 06/10/2020
WFH Advisory: availability of desmopressin pending re-start of intranasal desmopressin manufacture

The Perfect Fit – Tailoring hemophilia A management to each unique patient
CHS/SCH | 06/10/2020
Chapters of the CHS would like to invite you to a special webinar intended for Canadian patients and caregivers only. The learning objectives are: Overview of current treatment approaches...

Products in the pipeline
CHS/SCH | 23/09/2020
It is an exciting time in the treatment of people with bleeding disorders with many coagulation products having been recently approved by Health Canada or “in the pipeline” at...

Features
- CHS/SCH | 09/09/2020
  Coagulation products
- CHS/SCH | 06/08/2020
  Plasma Saves Lives: Addressing the COVID-19 Pandemic
- Ryan Borle | 04/08/2020
  Hemophilia Research Million Dollar Club – Report from the chair
- David Page | 23/07/2020
  Update of Phase 2b trial of UniQure’s AMT-061 gene therapy trial in hemophilia B
- Debbie Hum | 23/07/2020
  New hemophilia guidelines introduced at WFH Virtual Summit 2020
- Kathy Lawday | 23/07/2020
  Inhibitors – think differently
- Erin McCabe | 23/07/2020
  Musculoskeletal hot topic debates
- David Page | 22/07/2020
  OCTOSTIM SPRAY discontinued

INNOVATORS

BUILDER

Believers